TRxADE HEALTH Inc (MEDS) Q1 2023 Earnings Call Transcript
TRxADE HEALTH Inc (NASDAQ: MEDS) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Prashant Patel — Interim Chief Financial Officer Suren...
TRxADE HEALTH Inc (NASDAQ: MEDS) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Prashant Patel — Interim Chief Financial Officer Suren...
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations...
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Traci McCarty — Group Vice President, Investor...
Centene Corporation (NYSE: CNC) reported total revenue of $38.8 billion compared to $37.1 billion in the same period a year...
TRxADE HEALTH Inc (NASDAQ:MEDS) Q4 2022 Earnings Call dated Mar. 27, 2023. Corporate Participants: Prashant Patel — Chief Financial Officer Surendra Ajjarapu — Founder,...
RVL Pharmaceuticals plc (NASDAQ: RVLP) Q4 2022 earnings call dated Mar. 20, 2023 Corporate Participants: Lisa Wilson — Investor Relations Brian Markison — Chief...
BioLife Solutions Inc (NASDAQ: BLFS) Q4 2022 earnings call dated Mar. 16, 2023 Corporate Participants: Troy Wichterman — Chief Financial Officer Michael...
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Matt Roache — Director of Investor Relations...
CVS Health Corporation (NYSE: CVS) Q4 2022 earnings call dated Feb. 08, 2023 Corporate Participants: Tom Kelly — Senior Vice President of...
Cigna Corporation (NYSE: CI) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ralph Giacobbe — Senior Vice President of Investor...
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations...
GoHealth Inc (NASDAQ:GOCO) Q3 2022 Earnings Call dated Nov. 10, 2022. Corporate Participants: Brian Farley — Chief Legal Officer Vijay Kotte — Chief Executive...
BioLife Solutions Inc (NASDAQ:BLFS) Q3 2022 Earnings Call dated Nov. 09, 2022. Corporate Participants: Troy Wichterman — Chief Financial Officer Michael Rice — Chairman...
TRxADE Health Inc (NASDAQ:MEDS) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Janet Huffman — Chief Financial Officer Suren Ajjarapu — Founder,...
FibroGen Inc (NASDAQ:FGEN) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Michael Tung — Investor Relations Enrique Conterno — Chief Executive Officer...
Cara Therapeutics Inc (NASDAQ:CARA) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Matthew Murphy — Investor Relations Manager Christopher Posner — Chief...
Cigna Corporation (NYSE:CI) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Ralph Giacobbe — Head of IR David Cordani — Chairman of...
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Atabak Mokari — CFO Joseph Belanoff — CEO Sean Maduck — President...
Amgen Inc (NASDAQ:AMGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Arvind Sood — Vice President of Investor Relations Bob...
Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Matt Roache — Director of Investor Relations Thomas...
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Ryan Crowe — Vice President, Investor Relations Leonard...